Limiting glucose availability for tumours by adapting into ketosis may therefore create a metabolically unfavourable environment for tumour growth, whilst also reducing insulin and IGF-1′s growth and division stimulating signals [150]. The gene discussed is IGF1; the disease is neoplasm.